Phase 2 Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older at the time of signing the consent form
- You have been diagnosed with Arrhythmogenic Cardiomyopathy (a specific heart condition) based on established medical criteria
Who may not be able to join:
- You have a known allergy or sensitivity to atorvastatin (a cholesterol medication) or any of its ingredients
- You have moderate or severe liver disease
- You have a diagnosed muscle disease
- Your heart's pumping strength (left ventricle) is below a certain level (confirm with trial site)
- You have severe heart failure symptoms that significantly limit your daily activities (confirm with trial site)
- You have another type of heart condition, such as a different cardiomyopathy, significant heart valve problems, high blood pressure in the lungs, or a heart defect present from birth
- You have high cholesterol that requires treatment with cholesterol-lowering medication
- You have had a heart transplant
- Your expected life expectancy is less than 2 years
- You have another medical condition that the study doctor believes makes participation unsafe or unreliable (confirm with trial site)
- You are currently taking certain medications that can interact with the study drug, including some antibiotics (e.g., erythromycin, clarithromycin), antifungals, HIV medications, or certain others (confirm with trial site)
- You are currently taking fusidic acid, an antibiotic used for bacterial infections
- You are taking certain antiviral medications used to treat Hepatitis C (confirm with trial site)
- You are currently taking any other cholesterol-lowering medications, including statins or similar drugs
- You are taking medications primarily used as antioxidants
- You have taken part in another clinical trial involving an experimental drug within the last 30 days (or longer, depending on the drug used)
- You are pregnant or currently breastfeeding
- You are a woman who could become pregnant and are not using adequate contraception
- You have a known dependency on alcohol or drugs
- You are unable to have a cardiac MRI scan (a special heart imaging test)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Claudio Tondo, Centro Cardiologico Monzino IRCCS
Phone: +39 0258002752
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy of Atorvastatin in avoiding functional right ventricular deterioration
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.